Home > News > Headline News > Archive

Click on title to read the full article.

Novartis drug Afinitor® helps women with advanced breast cancer live significantly longer without their disease progressing

September 27, 2011

A pivotal Phase III study shows Afinitor® (everolimus) tablets plus exemestane, a hormonal therapy, more than doubled the time women lived without tumor growth (progression-free survival; PFS) and significantly reduced the risk of cancer progression by 57% versus exemestane alone in patients with advanced breast cancer[1].

Roche's T-DM1 Cancer Drug Delays Breast Cancer's Advance -Study

September 27, 2011

By Sten Stovall

Women with an aggressive type of advanced breast cancer can live significantly longer without their disease getting worse if they are treated with Roche Holding AG's (ROG.VX) experimental drug T-DM1, researchers said Sunday.



Virus kills breast cancer cells in laboratory

September 24, 2011

By Penn State University

A nondisease-causing virus kills human breast cancer cells in the laboratory, creating opportunities for potential new cancer therapies, according to Penn State College of Medicine researchers who tested the virus on three different breast cancer types that represent the multiple stages of breast cancer development.

Guidelines reflect changes in radiotherapy for bone metastases

September 24, 2011

By Bryant Furlow, BA

Metastatic bone tumors are a major cause of suffering and functional impairment for patients with cancer, degrading quality of life. It also represents the single most frequent cause of pain encountered in clinical oncology.1 Bone metastases can also cause debilitating complications such as spinal cord compression, pathogenic bone fractures, and hypercalcemia.

Film traces Pathfinder program, cancer patients' journey through it

September 24, 2011

By Kelly Poe

What should medicine do for you when it cannot save your life? A Duke University graduate and lecturer is attempting to answer that question in a film premiering Friday at the Nasher Museum of Art.
"What Love Is: The Duke Pathfinders 50" follows social worker Tina Staley as she attempts to supplement medical care with psychosocial care.

Tailored Breast Cancer Drugs in Focus at Cancer Meet

September 22, 2011

Doctors and investors at a cancer conference starting on Friday will be keen to find out more on the effectiveness of two promising new breast cancer drugs from Swiss drugmakers Roche and Novartis. Roche's T-DM1 and Novartis's Afinitor have been designed to treat two specific types of breast cancer and are among the latest examples of the tailored therapies increasingly being used in oncology.

Welsh scientists make crucial breast cancer research breakthrough

September 17, 2011

By Madeleine Brindley

WELSH researchers believe they have made a scientific breakthrough which could help end the spectre of patients dying from breast cancer. PhD student Luke Piggott has discovered a way to prevent breast cancer spreading around the body by killing its so-called cancer stem cells, which allow tumours to spread throughout the body.

MBCS: Newer Bone Drug Questioned Over Cost

September 13, 2011

By Crystal Phend

Denosumab (Xgeva) may not be cost-effective for the prevention of skeletal-related events in breast cancer with bone metastasis, researchers cautioned.

Emerging Therapy for Metastatic Breast Cancer Reported at Interventional Radiology Symposium Sponsored by Merit Medical Systems

September 13, 2011

A new treatment for metastatic breast cancer using transarterial chemoembolization (TACE) for targeted drug delivery was presented at the CIRSE scientific symposium

MBCS: PET-CT Imaging Points to Bone Met Prognosis

September 10, 2011

By Crystal Phend, Med Page Today

SAN FRANCISCO -- Metabolic activity of bone metastases measured with PET-CT imaging predicted breast cancer patients' prognosis, researchers found.

 1 2 >